Incannex Healthcare Inc.
About Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $12.0K
- Net income
- -$46.9M
- Total assets
- $20.4M
- Market cap
- $34.9M
- Operating margin
- -27661.6%
- Net margin
- -54517.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $86.0K
- Operating expenses
- $23.9M
- Operating income
- -$23.8M
- Net income
- -$46.9M
- EPS (basic)
- $-1.35
- EPS (diluted)
- $-1.35
Balance sheet
- Total assets
- $20.4M
- Current assets
- $20.0M
- Total liabilities
- $7.1M
- Current liabilities
- $7.0M
- Shareholders’ equity
- $13.4M
Cash flow
- Operating cash flow
- -$12.5M
- Investing cash flow
- -$8.0K
- Financing cash flow
- $21.4M
- Net cash flow
- $9.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $34.9M
- EPS (diluted)
- $-1.35
- Shares outstanding
- 10.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 25, 2022
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $46.9M in FY2024.
- Revenue grew 617% from FY2024 to FY2025.
- Trading 93% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Incannex Healthcare Inc..
Write a review
News about Incannex Healthcare Inc.
News & sentiment via Polygon.io
